全文获取类型
收费全文 | 96033篇 |
免费 | 7856篇 |
国内免费 | 3180篇 |
专业分类
耳鼻咽喉 | 495篇 |
儿科学 | 3492篇 |
妇产科学 | 1235篇 |
基础医学 | 15535篇 |
口腔科学 | 1344篇 |
临床医学 | 10048篇 |
内科学 | 20477篇 |
皮肤病学 | 1208篇 |
神经病学 | 1941篇 |
特种医学 | 1405篇 |
外国民族医学 | 8篇 |
外科学 | 7698篇 |
综合类 | 13202篇 |
现状与发展 | 22篇 |
预防医学 | 16819篇 |
眼科学 | 652篇 |
药学 | 6525篇 |
52篇 | |
中国医学 | 1828篇 |
肿瘤学 | 3083篇 |
出版年
2024年 | 190篇 |
2023年 | 1474篇 |
2022年 | 3574篇 |
2021年 | 4384篇 |
2020年 | 4005篇 |
2019年 | 3242篇 |
2018年 | 3222篇 |
2017年 | 3170篇 |
2016年 | 3560篇 |
2015年 | 3990篇 |
2014年 | 6105篇 |
2013年 | 6749篇 |
2012年 | 6049篇 |
2011年 | 6552篇 |
2010年 | 5046篇 |
2009年 | 4626篇 |
2008年 | 4461篇 |
2007年 | 4631篇 |
2006年 | 4297篇 |
2005年 | 3763篇 |
2004年 | 3202篇 |
2003年 | 2786篇 |
2002年 | 2111篇 |
2001年 | 1997篇 |
2000年 | 1633篇 |
1999年 | 1483篇 |
1998年 | 1253篇 |
1997年 | 1224篇 |
1996年 | 1018篇 |
1995年 | 1003篇 |
1994年 | 941篇 |
1993年 | 766篇 |
1992年 | 625篇 |
1991年 | 553篇 |
1990年 | 445篇 |
1989年 | 431篇 |
1988年 | 368篇 |
1987年 | 278篇 |
1986年 | 228篇 |
1985年 | 409篇 |
1984年 | 251篇 |
1983年 | 194篇 |
1982年 | 189篇 |
1981年 | 150篇 |
1980年 | 100篇 |
1979年 | 96篇 |
1978年 | 71篇 |
1977年 | 51篇 |
1976年 | 60篇 |
1975年 | 21篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
101.
Mariela Dutra Gontijo Moura Soraya de Mattos Camargo Grossmann Linaena Méricy da Silva Fonseca Maria Inês Barreiros Senna Ricardo Alves Mesquita 《Journal of oral pathology & medicine》2006,35(6):321-326
BACKGROUND: Oral hairy leukoplakia (OHL) may be an indicator of the progression of Human Immunodeficiency Virus (HIV)-induced immuno-depression, and the evaluation of risk factors leading to OHL is important in the management of these HIV-infected patients. However, there are few studies that analyze risk factors leading to OHL in the Brazilian population. The aim of this case-control study is to present data about prevalence rates and risk factors leading to OHL in a sample of HIV-infected adults in Brazil. METHODS: This case-control study included 111 HIV-infected patients treated at a clinic for sexually transmitted diseases and HIV. In the initial examinations with dentists, variables were collected from all patients. Diagnosis of OHL was performed in accordance with the International Classification System and cytological features. The Fisher and the chi-squared tests were used for statistical analysis. The proportional prevalence and odds ratio were estimated. RESULTS: Outcome presented a positive, statistically significant association among the presence of OHL and viral load of 3000 copies/mul or greater (P = 0.0001; odds ratio (OR) = 5.8), presence of oral candidiasis (P = 0.0000; OR = 11.1), previous use of fluconazole (P = 0.0000; OR = 24.6), and use of systemic acyclovir (P = 0.032; OR = 4.3). Antiretroviral medication presented a negative, statistically significant association with the presence of OHL (P = 0.002; OR = 8.4). CONCLUSIONS: Prevalence of OHL was 28.8%. Viral load, oral candidiasis, previous use of fluconazole, and systemic acyclovir were determined to be risk factors for OHL. Antiretroviral medication proved to be protective against the development of OHL. 相似文献
102.
MASAFUMI IKEDA SHIGETOSHI FUJIYAMA MOTOHIKO TANAKA MICHIO SATA TATSUYA IDE HIROSHI YATSUHASHI HIROSHI WATANABE 《Journal of gastroenterology and hepatology》2006,21(1):122-128
Background and Aim: This study investigated the clinical features of hepatocellular carcinoma in patients with sustained virological response to interferon for hepatitis C viral (HCV) infection. Methods: A total of 7715 patients with HCV infection were treated with interferon and followed up for more than 1 year after withdrawal of interferon in 64 Japanese hospitals and clinics between July 1988 and August 2001. Sustained virological response was obtained in 2515 (32.6%) patients. Of these 2515 patients, clinical data were collected for 38 patients in whom hepatocellular carcinoma developed. Sustained virological response was defined as HCV RNA negativity more than 6 months after the termination of interferon. Results: All patients were HCV RNA negative at the time of diagnosis of hepatocellular carcinoma. The median period until the detection of hepatocellular carcinoma was 4.7 years (range 1.4–9.0 years). There were significant improvements in hepatic function including serum albumin, aspartate aminotransferase, alanine aminotransferase, indocyanine green test, platelet count and histological activity grade in comparison with those before interferon therapy and at the onset of hepatocellular carcinoma. The maximum tumor size in patients without medical follow‐up for 1 year or more (median: 60 mm) was significantly larger than in patients who were periodically followed up for 6 months or less (median: 25 mm) (P = 0.002). Conclusions: The present findings emphasize the importance of regular medical follow up of patients with HCV infection, as even patients showing a sustained virological response to interferon and in whom hepatic function has improved have the potential to develop hepatocellular carcinoma. 相似文献
103.
Eimear Kieran 《Current Obstetrics & Gynaecology》2006,16(4):218-225
104.
105.
Sachiko Goto Akiyoshi Tsuji Teiko Murai Minoru Nishida Hiroko Tsukano Haruo Watanabe 《Journal of infection and chemotherapy》1998,4(1):16-19
Although there are effective antibacterial agents against plague, newer antibacterial agents have been developed which show
more potent activity against other bacterial organisms, but have not been tested againstYersinia pestis. A strain ofYersinia pestis was selected (no. 22; National Institute of Infectious Diseases, Tokyo, Japan) that caused a systemic infection in mice.Y. pestis no. 22 was intraperitoneally inoculated into DDY-strain mice, and 13 oral or 6 injectable antibacterial drugs given to the
infected mice at varying doses 1 and 24 hours after infection. Levofloxacin, sparfloxacin and ofloxacin were the most effective
oral agents against the infection, and prulifloxacin and pazufloxacin were also effective but to a lesser extent. Also, gentamicin
and arbekacin were the most potent injectable antibacterial agents againstY. pestis. These results suggest that there are several new drugs, both oral and injectable, which exert excellent in vivo antibacterial
activity against a mouse infection model and may be useful for the clinical treatment of plague. 相似文献
106.
采用免疫组织化学S-P法检测52例手术切除乳腺癌组织c-erbB-2蛋白和HSV-1、HSV-2表达情况。结果发现癌组织中c-erbB-2阳性34例(65.4%);HSV-1阳性38例(73.1%);HSV-2阳性15例(28.8%)。癌旁组织32例,阳性分别为3例(9.4%);12例(37.5%);2例(6.3%)。乳腺癌中c-erbB-2阳性率明显高于癌旁组织。乳腺癌及癌旁的HSV-1阳性率明 相似文献
107.
静脉毒瘾者84例HGV感染状况 总被引:8,自引:0,他引:8
目的调查庚型肝炎病毒(HGV)在静脉毒瘾者中的感染状况。方法采用逆转录聚合酶链反应(RT-PCR)检测84例静脉毒瘾者血浆标本。HGVRNA经热变性法提取后逆转录为cDNA,在HGV5′非编码区(5′NCR)设计两对引物进行巢式扩增,产物为238bp,并经限制性内切酶HpaⅡ鉴定扩增产物来自HGV。结果84例中有15例为HGVRNA阳性,阳性率为17.9%。HGVRNA阳性病例中11例合并丙型肝炎病毒感染(11/15)。结论静脉毒瘾者是HGV感染的高危人群;不洁注射是获得HGV感染的重要途径。 相似文献
108.
Cytologic evaluation of the CSF is often difficult when trying to distinguish between truly neoplastic and reactive cells. Several non-neoplastic conditions may be associated with atypical cells in the CSF, a fact the clinician has to consider to avoid inadequate aggressive theraphies. We report here three patients with infectious meningitis (due to Herpes zoster virus in two, and neuroborreliosis in one) and cytologically atypical cerebrospinal fluid lymphocytes. Further characterization showed that the pleocyrosis in these patients was of reactive origin. Cytomorphology is frequently insufficient and histochemical, immuncytochemical and cellular genome analysis techniques may help differentiate atypical reactive cells from neoplastic cells. 相似文献
109.
目的 探讨难治性支气管—肺部感染(难治组)衣原体、支原体两种病原体的表达。方法 应用ELISA法检测了29例难治性支气管—肺部感染两种非典型病原体急性感染指标,衣原体抗体IgM、支原体抗体IgM及冷凝集实验,并常规细菌学检查,与同期住院的普通性下呼吸道感染(普通组)40例,门诊及住院的急性上呼吸道感染(上感组)30例进行比较。结果 难治组衣原体急性感染率68.9%,显著高于普通组、上感组,上感组最低;支原体急性感染率难治组34、5%,显著高于普通组、上感组;衣原体混合支原体、衣原体混合其他致病菌感染均显著高于普通组和上感组。结论 难治性下呼吸道感染中衣原体、支原体感染率较高,且易与多种病原体混合感染,衣原体的慢性感染可能是难治感染的重要原因。 相似文献
110.
Hitoshi Tajiri M.D Kosuke Kozaiwa M.D Tokuzo Harada M.D Yoshikazu Ozaki M.D Kazunori Miki M.D Kazuo Shimizu M.D Shintaro Okada M.D. 《Pediatrics international》1991,33(3):323-326
We assessed the efficacy of a government-sponsored mass protection program in Osaka, Japan, for perinatal HBV infection in infants born to HBeAg positive HBV carrier mothers. We also evaluated the impact of optional follow-up procedures in such infants, including an evaluation of anti-HBs response and a booster dose of HBV vaccine for poor responders. The results demonstrated that this mass protection program protected 94.4% of the infants from perinatal HBV infection in the Osaka area. However, the proportion of infants with an unprotective level of anti-HBs was higher in the standard group than in the follow-up group both at 1.0 and 1.5 years of age, which was also the case for HBV events. Furthermore, the present study showed that a booster dose of vaccine in poor responders was very effective in promoting an anti-HBs response. In conclusion, we recommend that a follow-up blood test to confirm a response of anti-HBs to HBV vaccine should be performed at 4–8 weeks after the third injection of HBV vaccine in infants born to HBeAg positive HBV carrier mothers. We also recommend that a booster injection of HBV vaccine should be immediately given to poor responding infants who otherwise are at a considerable risk of developing HBV infection in late infancy. 相似文献